Jerry S Powell

Title(s)Professor Emeritus, Hematology and Oncology
SchoolSchool of Medicine
AddressCancer Ctr So, #3016
CA 95817
Phone916-734-3772
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Quantitative HLA-class-II/factor VIII (FVIII) peptidomic variation in dendritic cells correlates with the immunogenic potential of therapeutic FVIII proteins in hemophilia A. J Thromb Haemost. 2020 01; 18(1):201-216. Diego VP, Luu BW, Hofmann M, Dinh LV, Almeida M, Powell JS, Rajalingam R, Peralta JM, Kumar S, Curran JE, Sauna ZE, Kellerman R, Park Y, Key NS, Escobar MA, Huynh H, Verhagen AM, Williams-Blangero S, Lehmann PV, Maraskovsky E, Blangero J, Howard TE. PMID: 31556206.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    2. Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A. Haemophilia. 2016 Sep; 22(5):730-8. Klamroth R, Simpson M, von Depka-Prondzinski M, Gill JC, Morfini M, Powell JS, Santagostino E, Davis J, Huth-Kühne A, Leissinger C, Neumeister P, Bensen-Kennedy D, Feussner A, Limsakun T, Zhou M, Veldman A, St Ledger K, Blackman N, Pabinger I. PMID: 27434619.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    3. Longer-acting clotting factor concentrates for hemophilia. J Thromb Haemost. 2015 Jun; 13 Suppl 1:S167-75. Powell JS. PMID: 26149018.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    4. Placenta as a Source of Stem Cells for Regenerative Medicine. Current Pathobiology Reports. 2015 Mar 1; 3(1):9-16. Meierhenry MJ, Ryzhuk RV, Miguelino MM, Lankford LL, Powell PJ, Farmer FD, Wang WA. .
      View in: Publisher Site   Mentions:
    5. Lasting power of new clotting proteins. Hematology Am Soc Hematol Educ Program. 2014 Dec 05; 2014(1):355-63. Powell JS. PMID: 25696879.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    6. Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study. Br J Haematol. 2015 Jan; 168(1):124-34. Powell JS, Apte S, Chambost H, Hermans C, Jackson S, Josephson NC, Mahlangu JN, Ozelo MC, Peerlinck K, Pasi J, Perry D, Ragni MV, Wang X, Jiang H, Li S, Cristiano LM, Innes A, Nugent K, Brennan A, Luk A, Allen G, Pierce GF, Robinson B. PMID: 25208598.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    7. Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates. Br J Haematol. 2015 Jan; 168(1):113-23. Powell J, Shapiro A, Ragni M, Negrier C, Windyga J, Ozelo M, Pasi J, Baker R, Potts J, Li S, Mei B, Pierce GF, Robinson B. PMID: 25209873.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    8. Alprolix (recombinant Factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B. Expert Rev Hematol. 2014 Oct; 7(5):559-71. Ducore JM, Miguelino MG, Powell JS. PMID: 25142322.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    9. Clinical utility and patient perspectives on the use of extended half-life rFIXFc in the management of hemophilia B. Patient Prefer Adherence. 2014; 8:1073-83. Miguelino MG, Powell JS. PMID: 25143713; PMCID: PMC4133029.
      View in: PubMed   Mentions: 3  
    10. Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures. Transfusion. 2015 Jan; 55(1):45-50. Janbain M, Nugent DJ, Powell JS, St-Louis J, Frame VB, Leissinger CA. PMID: 25070582.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    11. Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study. Haemophilia. 2014 May; 20(3):354-61. Lalezari S, Coppola A, Lin J, Enriquez MM, Tseneklidou-Stoeter D, Powell J, Ingerslev J, LIPLONG Investigators. PMID: 24847524.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A. J Thromb Haemost. 2014 Apr; 12(4):488-96. Coyle TE, Reding MT, Lin JC, Michaels LA, Shah A, Powell J. PMID: 24843882; PMCID: PMC4265842.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimalsCTClinical Trials
    13. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med. 2013 Dec 12; 369(24):2313-23. Powell JS, Pasi KJ, Ragni MV, Ozelo MC, Valentino LA, Mahlangu JN, Josephson NC, Perry D, Manco-Johnson MJ, Apte S, Baker RI, Chan GC, Novitzky N, Wong RS, Krassova S, Allen G, Jiang H, Innes A, Li S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Nugent K, Vigliani G, Brennan A, Luk A, Pierce GF, B-LONG Investigators. PMID: 24304002.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansCTClinical Trials
    14. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A. Blood. 2014 Jan 16; 123(3):317-25. Mahlangu J, Powell JS, Ragni MV, Chowdary P, Josephson NC, Pabinger I, Hanabusa H, Gupta N, Kulkarni R, Fogarty P, Perry D, Shapiro A, Pasi KJ, Apte S, Nestorov I, Jiang H, Li S, Neelakantan S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Dodd N, Nugent K, Vigliani G, Luk A, Brennan A, Pierce GF, A-LONG Investigators. PMID: 24227821; PMCID: PMC3894491.
      View in: PubMed   Mentions: 153     Fields:    Translation:HumansCTClinical Trials
    15. Molecular approaches for improved clotting factors for hemophilia. Blood. 2013 Nov 21; 122(22):3568-74. Kaufman RJ, Powell JS. PMID: 24065241; PMCID: PMC3837506.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    16. Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates. Transfusion. 2013 May; 53(5):1143-4. Soucie JM, Monahan PE, Kulkarni R, De Staercke C, Recht M, Chitlur MB, Gruppo R, Hooper WC, Kessler C, Manco-Johnson MJ, Powell J, Pyle M, Riske B, Sabio H, Trimble S. PMID: 23659532.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    17. Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitors. Haemophilia. 2013 May; 19(3):e151-66. Valentino LA, Allen G, Gill JC, Hurlet A, Konkle BA, Leissinger CA, Luchtman-Jones L, Powell J, Reding M, Stine K. PMID: 23374141.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Hum Mol Genet. 2013 May 01; 22(9):1903-10. Lane J, McLaren PJ, Dorrell L, Shianna KV, Stemke A, Pelak K, Moore S, Oldenburg J, Alvarez-Roman MT, Angelillo-Scherrer A, Boehlen F, Bolton-Maggs PH, Brand B, Brown D, Chiang E, Cid-Haro AR, Clotet B, Collins P, Colombo S, Dalmau J, Fogarty P, Giangrande P, Gringeri A, Iyer R, Katsarou O, Kempton C, Kuriakose P, Lin J, Makris M, Manco-Johnson M, Tsakiris DA, Martinez-Picado J, Mauser-Bunschoten E, Neff A, Oka S, Oyesiku L, Parra R, Peter-Salonen K, Powell J, Recht M, Shapiro A, Stine K, Talks K, Telenti A, Wilde J, Yee TT, Wolinsky SM, Martinson J, Hussain SK, Bream JH, Jacobson LP, Carrington M, Goedert JJ, Haynes BF, McMichael AJ, Goldstein DB, Fellay J, NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI). PMID: 23372042; PMCID: PMC3613165.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    19. Molecular approaches for improved clotting factors for hemophilia. Hematology Am Soc Hematol Educ Program. 2013; 2013:30-6. Kaufman RJ, Powell JS. PMID: 24319159.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study. Thromb Haemost. 2012 Nov; 108(5):913-22. Powell J, Martinowitz U, Windyga J, Di Minno G, Hellmann A, Pabinger I, Maas Enriquez M, Schwartz L, Ingerslev J, LipLong Study Investigators. PMID: 23014711.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    21. Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening. Transfusion. 2013 Jun; 53(6):1217-25. Soucie JM, De Staercke C, Monahan PE, Recht M, Chitlur MB, Gruppo R, Hooper WC, Kessler C, Kulkarni R, Manco-Johnson MJ, Powell J, Pyle M, Riske B, Sabio H, Trimble S, US Hemophilia Treatment Center Network. PMID: 22998193; PMCID: PMC4519820.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsPHPublic Health
    22. Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients. Blood. 2012 Mar 29; 119(13):3031-7. Powell JS, Josephson NC, Quon D, Ragni MV, Cheng G, Li E, Jiang H, Li L, Dumont JA, Goyal J, Zhang X, Sommer J, McCue J, Barbetti M, Luk A, Pierce GF. PMID: 22223821; PMCID: PMC3646317.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCTClinical Trials
    23. Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients. Blood. 2012 Jan 19; 119(3):666-72. Shapiro AD, Ragni MV, Valentino LA, Key NS, Josephson NC, Powell JS, Cheng G, Thompson AR, Goyal J, Tubridy KL, Peters RT, Dumont JA, Euwart D, Li L, Hallén B, Gozzi P, Bitonti AJ, Jiang H, Luk A, Pierce GF. PMID: 22110246; PMCID: PMC3265197.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    24. The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study. Thromb Haemost. 2011 Aug; 106(2):279-88. Kessler CM, Friedman K, Schwartz BA, Gill JC, Powell JS, Wilate PK Study Investigators. PMID: 21725579.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    25. Recombinant factor VIII in the management of hemophilia A: current use and future promise. Ther Clin Risk Manag. 2009 Apr; 5(2):391-402. Powell JS. PMID: 19536318; PMCID: PMC2697540.
      View in: PubMed   Mentions: 12  
    26. The next generation of anti-haemophilia factor, factor VIII. Long-lasting protection from spontaneous bleeding, are we there yet? Thromb Haemost. 2008 Sep; 100(3):365-6. Powell J. PMID: 18766246.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Prophylaxis for adults with severe haemophilia: a compelling need for evidence-based guidelines. Haemophilia. 2008 Mar; 14(2):385-6. Walsh CE, Adult Prophylaxis Study Group. PMID: 18201188.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A. J Thromb Haemost. 2008 02; 6(2):277-83. Powell JS, Nugent DJ, Harrison JA, Soni A, Luk A, Stass H, Gorina E. PMID: 18039351.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    29. Liposomal approach towards the development of a longer-acting factor VIII. Haemophilia. 2007 Sep; 13 Suppl 2:23-8. Powell JS. PMID: 17685920.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    30. Reformulated BeneFix: efficacy and safety in previously treated patients with moderately severe to severe haemophilia B. Haemophilia. 2007 May; 13(3):233-43. Lambert T, Recht M, Valentino LA, Powell JS, Udata C, Sullivan ST, Roth DA. PMID: 17498071.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    31. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003. Haemophilia. 2005 Sep; 11(5):516-28. Goedert JJ, Second Multicenter Hemophilia Cohort Study. PMID: 16128897.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    32. "Wait-and-see": an alternative approach to managing acute hepatitis C with high-dose interferon-alpha monotherapy. Ann Intern Med. 2004 Sep 21; 141(6):W91-2. Pimstone NR, Pimstone D, Saicheur T, Powell J, Yu AS. PMID: 15381541.
      View in: PubMed   Mentions:    Fields:    
    33. Long-term correction of hyperglycemia in diabetic mice after implantation of cultured human cells derived from fetal pancreas. Pancreas. 2004 Jul; 29(1):e23-9. Wu F, Jagir M, Powell JS. PMID: 15211120.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    34. Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P). Haemophilia. 2004 Jan; 10(1):42-51. Thompson AR, Gill JC, Ewenstein BM, Mueller-Velten G, Schwartz BA, Humate-P Study Group. PMID: 14962219.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    35. Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy. Haemophilia. 2003 Nov; 9(6):688-95. Gill JC, Ewenstein BM, Thompson AR, Mueller-Velten G, Schwartz BA, Humate-P Study Group. PMID: 14750934.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    36. Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion. Blood. 2003 Sep 15; 102(6):2038-45. Powell JS, Ragni MV, White GC, Lusher JM, Hillman-Wiseman C, Moon TE, Cole V, Ramanathan-Girish S, Roehl H, Sajjadi N, Jolly DJ, Hurst D. PMID: 12763932.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCellsCTClinical Trials
    37. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thromb Haemost. 2002 Jan; 87(1):52-7. DiMichele DM, Kroner BL, North American Immune Tolerance Study Group. PMID: 11848456.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    38. Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America. Haemophilia. 2001 May; 7(3):235-41. Cohen AJ, Kessler CM, Ewenstein BM, Hemophilia Research Society of North America. PMID: 11380626.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Lead arthropathy and systemic lead poisoning from an intraarticular bullet. AJR Am J Roentgenol. 2001 May; 176(5):1144. DeMartini J, Wilson A, Powell JS, Powell CS. PMID: 11312168.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    40. Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study Group. Thromb Haemost. 2000 Jun; 83(6):811-6. Abshire TC, Brackmann HH, Scharrer I, Hoots K, Gazengel C, Powell JS, Gorina E, Kellermann E, Vosburgh E. PMID: 10896230.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    41. Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80 degrees C terminal dry heat treatment in patients with haemophilia A. Haemophilia. 2000 May; 6(3):140-9. Powell JS, Bush M, Harrison J, Abildgaard C, Vosburgh E, Thompson AR, Hurst D. PMID: 10792471.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    42. Novel vascular sealing device for closure of percutaneous vascular access sites. Cathet Cardiovasc Diagn. 1998 Sep; 45(1):82-8; discussion 90-1. Gershony G, Brock JM, Powell JS. PMID: 9736360.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    43. Induction of human factor VIII inhibitors in rats 2: Fine mapping of rat anti-human rFVIII antibodies. Thromb Haemost. 1996 Dec; 76(6):998-1003. Levin LG, Jarvis M, Powell J, Harrison JA, Reisner HM. PMID: 8972024.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    44. Polylysine enhances cationic liposome-mediated transfection of the hepatoblastoma cell line Hep G2. Biotechnol Appl Biochem. 1996 06; 23(3):217-20. Mack KD, Walzem RL, Lehmann-Bruinsma K, Powell JS, Zeldis JB. PMID: 8679107.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    45. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype. Thromb Haemost. 1996 Feb; 75(2):318-25. Jarvis MA, Levin LG, Harrison JA, DePianto DJ, Suzuki CM, Ziaja CL, Brown JE, Jolly KW, Reisner HM, Abildgaard CF, Powell JS. PMID: 8815584.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsPHPublic Health
    46. Hepatic gene expression after direct DNA injection. Advanced Drug Delivery Reviews. 1995 Dec 1; 17(3):265-271. Hickman HM, Malone MR, Sih ST, Akita AG, Carlson CD, Powell PJ. .
      View in: Publisher Site   Mentions:
    47. Vascular endothelial growth factor causes endothelial proliferation after vascular injury. Biochem Biophys Res Commun. 1995 Feb 06; 207(1):348-54. Burke PA, Lehmann-Bruinsma K, Powell JS. PMID: 7857288.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    48. Gene expression following direct injection of DNA into liver. Hum Gene Ther. 1994 Dec; 5(12):1477-83. Hickman MA, Malone RW, Lehmann-Bruinsma K, Sih TR, Knoell D, Szoka FC, Walzem R, Carlson DM, Powell JS. PMID: 7711140.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    49. Dexamethasone enhancement of gene expression after direct hepatic DNA injection. J Biol Chem. 1994 Nov 25; 269(47):29903-7. Malone RW, Hickman MA, Lehmann-Bruinsma K, Sih TR, Walzem R, Carlson DM, Powell JS. PMID: 7961986.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    50. Effect of cilazapril on the proliferative response after vascular damage. J Cardiovasc Pharmacol. 1993; 22 Suppl 4:S19-24. Lehmann K, Powell JS. PMID: 7523769.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    51. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension. 1991 Oct; 18(4 Suppl):II70-6. Hanson SR, Powell JS, Dodson T, Lumsden A, Kelly AB, Anderson JS, Clowes AW, Harker LA. PMID: 1833327.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    52. Role of angiotensin II in injury-induced neointima formation in rats. Hypertension. 1991 Oct; 18(4 Suppl):II60-4. Osterrieder W, Müller RK, Powell JS, Clozel JP, Hefti F, Baumgartner HR. PMID: 1833325.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    53. Heparin and cilazapril together inhibit injury-induced intimal hyperplasia. Hypertension. 1991 Oct; 18(4 Suppl):II65-9. Clowes AW, Clowes MM, Vergel SC, Müller RK, Powell JS, Hefti F, Baumgartner HR. PMID: 1833326.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    54. Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 1991 May; 17(6 Suppl B):137B-142B. Powell JS, Muller RK, Baumgartner HR. PMID: 1826694.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    55. Vascular protection with cilazapril. Drugs. 1991; 41 Suppl 1:62-7. Clozel JP, Powell JS, Kuhn H, Müller RK, Hefti F, Baumgartner HR. PMID: 1712274.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    56. Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction in vascular smooth muscle cells. Basic Res Cardiol. 1991; 86 Suppl 1:65-74. Powell JS, Rouge M, Müller RK, Baumgartner HR. PMID: 1827985.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    57. Development of a new radioimmunoassay for erythropoietin using recombinant erythropoietin. Kidney Int. 1990 Nov; 38(5):969-75. Mason-Garcia M, Beckman BS, Brookins JW, Powell JS, Lanham W, Blaisdell S, Keay L, Li SC, Fisher JW. PMID: 2266682.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    58. Specific growth stimulation of cultured smooth muscle cells from spontaneously hypertensive rats by platelet-derived growth factor A-chain homodimer. Cell Regul. 1990 Oct; 1(11):821-31. Resink TJ, Scott-Burden T, Hahn AW, Rouge M, Hosang M, Powell JS, Bühler FR. PMID: 1965150; PMCID: PMC362849.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    59. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul. 1990 Aug; 1(9):649-59. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Bühler FR. PMID: 2078571; PMCID: PMC361629.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    60. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun. 1990 May 16; 168(3):1303-10. Resink TJ, Hahn AW, Scott-Burden T, Powell J, Weber E, Bühler FR. PMID: 2161221.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    61. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol. 1990; 16 Suppl 4:S42-9. Powell JS, Müller RK, Rouge M, Kuhn H, Hefti F, Baumgartner HR. PMID: 1705627.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    62. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989 Jul 14; 245(4914):186-8. Powell JS, Clozel JP, Müller RK, Kuhn H, Hefti F, Hosang M, Baumgartner HR. PMID: 2526370.
      View in: PubMed   Mentions: 120     Fields:    Translation:Animals
    63. Selective expression of mRNA encoding platelet-derived growth factor B chain following transfection of foreign genes into cell lines derived from baby hamster kidney. J Cell Biochem. 1989 Jan; 39(1):87-94. Sakariassen KS, Powell JS, Raines EW, Ross R. PMID: 2654148.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    64. Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. J Biol Chem. 1988 Nov 25; 263(33):17516-21. Dubé S, Fisher JW, Powell JS. PMID: 3182860.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    65. Recombinant human erythropoietin: purification and analysis of carbohydrate linkage. Arch Biochem Biophys. 1988 Sep; 265(2):329-36. Broudy VC, Tait JF, Powell JS. PMID: 3421710.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    66. Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed. J Clin Invest. 1987 Apr; 79(4):1153-9. Bernstein ID, Singer JW, Andrews RG, Keating A, Powell JS, Bjornson BH, Cuttner J, Najfeld V, Reaman G, Raskind W, et al. PMID: 3470307; PMCID: PMC424297.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    67. Pure red cell aplasia: response to therapy with anti-thymocyte globulin. Am J Hematol. 1986 Dec; 23(4):363-71. Abkowitz JL, Powell JS, Nakamura JM, Kadin ME, Adamson JW. PMID: 3098093.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    68. The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors. Blood. 1986 Nov; 68(5):1030-5. Andrews RG, Takahashi M, Segal GM, Powell JS, Bernstein ID, Singer JW. PMID: 3768529.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    69. Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization. Proc Natl Acad Sci U S A. 1986 Sep; 83(17):6465-9. Powell JS, Berkner KL, Lebo RV, Adamson JW. PMID: 3462706; PMCID: PMC386524.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    70. Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol. 1986 May; 63(1):59-67. Abkowitz JL, Kadin ME, Powell JS, Adamson JW. PMID: 3085703.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    71. Hematopoietic growth factors in human serum. erythroid burst-promoting activity in normal subjects and in patients with severe aplastic anemia. J Lab Clin Med. 1985 Oct; 106(4):384-92. Yen YP, Zabala P, Doney K, Clemons G, Gillis S, Powell JS, Adamson JW. PMID: 4045296.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    72. Platelet-derived growth factor enhances in vitro erythropoiesis via stimulation of mesenchymal cells. J Clin Invest. 1985 Jul; 76(1):137-42. Delwiche F, Raines E, Powell J, Ross R, Adamson J. PMID: 4019772; PMCID: PMC423728.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    73. The generation of human long-term marrow cultures from marrow depleted of Ia (HLA-DR) positive cells. Blood. 1984 Dec; 64(6):1159-62. Keating A, Powell J, Takahashi M, Singer JW. PMID: 6594169.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    74. A clonal complete remission in a patient with acute nonlymphocytic leukemia originating in a multipotent stem cell. N Engl J Med. 1984 Jun 07; 310(23):1513-7. Jacobson RJ, Temple MJ, Singer JW, Raskind W, Powell J, Fialkow PJ. PMID: 6717542.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    75. Human mixed cell colonies: unicellular or multicellular origin--analysis by G-6-PD. Br J Haematol. 1984 May; 57(1):89-95. Powell JS, Fialkow PJ, Adamson JW. PMID: 6722041.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    76. Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia. Leuk Res. 1984; 8(4):535-45. Singer JW, Keating A, Cuttner J, Gown AM, Jacobson R, Killen PD, Moohr JW, Najfeld V, Powell J, Sanders J, et al. PMID: 6471898.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    77. The spleen as a source of colony-forming cells in myelofibrosis. Prog Clin Biol Res. 1984; 154:323-34. Adamson JW, Powell JS. PMID: 6382301.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    78. Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: physical characteristics and requirements for growth. J Cell Physiol. 1984 Jan; 118(1):87-96. Kimura H, Burstein SA, Thorning D, Powell JS, Harker LA, Fialkow PJ, Adamson JW. PMID: 6690455.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    79. High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis. J Lab Clin Med. 1983 Oct; 102(4):613-20. Delwiche F, Garrity MJ, Powell JS, Robertson RP, Adamson JW. PMID: 6311928.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    80. Polycythemia vera: studies of hemopoiesis in continuous long-term culture of human marrow. J Cell Physiol Suppl. 1982; 1:79-85. Powell JS, Fialkow PJ, Adamson JW. PMID: 6950947.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    With one click, see people who:

    Mentor

    Offer Student Projects

    Run Clinical Trials

    See more options in the Advanced Search tab

    Jerry's Networks
    Concepts (399)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California